China national lung cancer screening guideline with low‐dose computed tomography (2015 version)

• Published in: Thoracic cancer Vol. 6; no. 6; pp. 812 - 818
• Main Authors: Zhou, Qing‐hua, Fan, Ya‐guang, Bu, Hong, Wang, Ying, Wu, Ning, Huang, Yun‐chao, Wang, Guiqi, Wang, Xin‐yun, Qiao, You‐lin
• Format: Journal Article
• Language: English
• Published: Singapore John Wiley & Sons, Inc 01.11.2015; John Wiley & Sons, Ltd
• Subjects: Cancer; Care and treatment; China; Clinical Guideline; CT imaging; Diagnosis; Evidence-based medicine; Family planning; Health aspects; low‐dose computed tomography; Lung cancer; lung cancer screening guideline; Mortality; Patient education; China; low-dose computed tomography; lung cancer screening guideline
• ISSN: 1759-7706; 1759-7714
• DOI: 10.1111/1759-7714.12287

Background Lung cancer is the leading cause of cancer‐related death in China. Results from a randomized controlled trial using annual low‐dose computed tomography (LDCT) in specific high‐risk groups demonstrated a 20% reduction in lung cancer mortality. Methods A China national lung cancer screening guideline was developed by lung cancer early detection and treatment expert group appointed by the National Health and Family Planning Commission, based on results of the National Lung Screening Trial, systematic review of evidence related to LDCT screening, and protocol of lung cancer screening program conducted in rural China. Results Annual lung cancer screening with LDCT is recommended for high risk individuals aged 50–74 years who have at least a 20 pack‐year smoking history and who currently smoke or have quit within the past five years. Individualized decision making should be conducted before LDCT screening. LDCT screening also represents an opportunity to educate patients as to the health risks of smoking; thus, education should be integrated into the screening process in order to assist smoking cessation. Conclusions A lung cancer screening guideline is provided for the high‐risk population in China.